Table 1.

Characteristics of the First PANGEA-HIV Consensus Sequences

	Africa Health Research Institute Resistance Cohort	Mochudi Prevention Project	Rakai Community Cohort Study	MRC/UVRI Uganda
Number of sequences	92	359	2,833	701
Number of individuals	92	351	2,820	694
Sex, %
F	73	73	56	51
M	27	24	44	32
Missing	0	3	0	16
Age at time of sampling, %
<25	10	17	25	11
25–29	20	21	28	13
30–34	16	18	22	20
35–39	24	14	15	19
40 or older	30	24	10	15
Missing	0	6	0	23
Serum/plasma HIV-1 RNA within 1 year of sampling date (copies/ml), %
<10,000	7	30	19	1
10,000–49,999	36	22	8	0
50,000–99,999	13	16	3	1
100,000 or higher	35	19	2	2
Missing	9	13	68	96
Self-reported ART use before sampling, %
Yes	100	3	6	0
No	0	91	94	90
Missing	0	6	0	10
Year of sampling, %
2009	0	0	0	35
2010	0	38	0	5
2011	55	36	25	0
2012	42	17	46	0
2013	2	7	19	40
2014	0	0	11	10
Missing	0	2	0	10
HIV-1 subtype, %
A1	0	0	19	23
B	0	0	0	2
C	94	93	3	1
D	0	0	30	21
Other	0	0	0	1
potentially recombinanta	6	3	33	38
<500 nt to determine subtype	0	4	15	14

^aAs identified with the COMET HIV-1 subtyping tool⁵² on four partial amplicon sequences, see Materials and Methods. More refined approaches are underway to confirm recombinant sequences among potentially recombinant sequences.